Pfizer shares fall after drugmaker drops weight-loss pill due to side effects
The Pfizer plant in Newbridge, Co Kildare
Pfizer is dropping the development of an experimental weight-loss pill due to side effects – a blow to the drug maker’s efforts to find new avenues for growth.
More than half of patients in a mid-stage study had to stop taking twice-daily danuglipron due to nausea and vomiting, according to a statement yesterday. The shares fell 3.9pc in trading before US markets opened.
.jpg)
.jpg)
